Top Shareholders of RVX FWIW
in response to
by
posted on
Mar 01, 2020 09:46AM
Per October 31, 2019 info circular.
Shenzhen Hepalink Pharmaceutical Co., Ltd. China -81,713,191 -39.0%
Eastern Capital Limited Cayman Islands -27,712,879 -13.2%
Per the annual info form, The directors and executive officers, in the aggregate, beneficially own, directly or indirectly, or exercise control or direction over 8,584,325, or 4.2%, of issued and outstanding Common Shares as of July 26, 2019. This includes, Don (he owns 4.6 million), Wong, Smith, Zuerblis, McNeil, Blin, Cann, Sweeney, Lebioda and Johansson
Ori Star – as per below, they own debentures which are convertible, so looks like 7million shares or so if converted, so say 4% if my math is in the ballpark, but there are so many weird terms to the actual agreement from what I remember, so maybe they can increase that percentage by using their leverage.
Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that it has issued a 10% secured convertible debenture in the principal amount of US$12 million (the “Debenture”) to a wholly-owned subsidiary of ORI Star Fund LP (“ORI” or the “Fund”). The Debenture bears interest at a rate of 10% per annum and matures on September 26, 2020. The Fund may elect to convert the Debenture into common shares of the Company at a conversion price equal to the lesser of CAD$2.54 per share and the 5-day volume weighted average trading price of the common shares on the date of conversion. The Company granted the Fund a security interest in all of its assets, including its patents and other intellectual property, as security for its obligations under the Debenture. In addition, the Fund received 600,000 common share purchase warrants exercisable until December 31, 2023 at a price of CAD$2.54 per share.